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Immunoglobulin D  (IgD) shows an unusual distribution in being found commonly 
on the cell surface of circulating normal human B lymphocytes, but only in very low 
amounts in the serum (1). Similarly, the incidence of IgD-producing myeloma is rare, 
perhaps  reflecting the  low  numbers  of normal  plasma cells which  secrete IgD  (2). 
Another unusual  feature of IgD is that although cell surface IgD displays the usual 
(two-thirds)  predominance  of  light  chains  of  the  K type,  the  myeloma  proteins 
described  have  been  very  largely  (90%)  of the  X light  chain  type  (3).  A  similar 
predominance of IgD X has also been demonstrated for normal human serum IgD (4). 
In  the  B  lymphocytic  neoplasm  chronic  lymphocytic  leukemia  (CLL),  IgD  is 
frequently found on the cell surface together with IgM of the same idiotype (5)  and 
the predominance of tumors bearing the ~ light chain type reflects that of the normal 
B  cell  population.  Some  cases  of  non-Hodgkin's  lymphoma  (NHL)  involving  B 
lymphocytes, usually of the well-differentiated lymphocytic group, also display IgD 
and IgM (6). 
In our studies on the ability of cells from patients with CLL to export Ig in culture 
(7), it was demonstrated that 9/9 exported IgM and that 3/9 were also able to export 
IgD:  in  two of the  cases where  anti-idiotypic antibody was available, the  IgD was 
shown to be of the same idiotype as the IgM. The three IgD-exporting cell populations 
were all of the )~ light chain type. 
The present investigation has been concerned with the patterns of Ig secretion of 23 
patients with CLL or NHL and has demonstrated export of IgD by 10/12 neoplastic 
cell populations which displayed surface Ig of the X type and no export of IgD by 11/ 
11 cell populations displaying surface Ig of the K type. 
Materials and Methods 
Preparation of Cells.  Peripheral blood was obtained from patients with CLL, all of which 
had elevated numbers of lymphoeytes (>3 ×  101°/liter). Lymphocytes were isolated by gradient 
centrifugation  at  37°C  as  described previously (7). The lymph nodes and  spleen  from the 
patients with NHL were chopped and passed through a sterile sieve to prepare cell suspensions 
before being separated by gradient centrifugation as for peripheral blood. Lymphocytes were 
finally suspended at 2 ×  107/ml in Eagle's minimal essential  medium (MEM) containing  1% 
nonessential  amino acids  (Flow Laboratories, Inc., Rockville,  MD), 2 mM L-glutamine,  100 
IU/ml of both penicillin  and streptomycin, and 10% fetal calf serum. Cells were swirled gently 
at 37°C, and samples were taken at intervals for assessment of Ig production in the supernatants. 
The  culture  period  was  usually  5-6  h  and  cell  viability was  monitored  by Trypan  blue 
* Supported by grants from the  Medical Research Council, the Cancer Research Campaign, and 
Tenovus of Cardiff, United Kingdom. 
J. Exp. MED. © The Rockefeller  University Press • 0022-1007/82/12/0337/05 $1.00  337 
Volume 156  December 1982  337-341 338  STEVENSON  ET AL.  BRIEF  DEFINITIVE REPORT 
exclusion.  Surface lg isotypes of cell  preparations  were examined  by immunofluorescence as 
described previously (7). 
Radioimmunoassay (RIA).  This was used to measure levels ofIgM, IgD, x, and ~ light chains 
in cell supernatants: the assays have been described previously (7), and it should be noted that 
the light chain assays are relatively insensitive to light chain in combination with # or 6 chain 
and that they are largely detecting free light chain. The RIA for IgD has also been described 
(7): the solid phase was Sephadex G-25 coupled to sheep antibody to normal human Fd 6 and 
radiolabeled  normal  human Fab ~ as antigen.  Normal human IgD obtained  from serum by 
immunosorption was used as a standard, and soybean trypsin inhibitor (20 #g/ml) was present 
in  the  RIA buffer  (7). The  assay  was  sensitive  to  IgD  in  the  range  of 1-200 #g/ml,  and 
specificity was demonstrated by <0.1% interference by IgM, x, or ~k light chains. 
Results 
The results of investigations of lymphocyte populations from 23 patients are shown 
in  Table  I  (cells  of the 3. chain  type)  and  Table  II  (cells  of the  K chain  type).  The 
surface Ig isotypes were monotypic with >95% of the cells  displaying only one light 
chain type; the two exceptions to this being patient Sto (Table I) who displayed both 
and  3. light  chains  but  who exported  only 3`, suggesting the  presence  of extrinsic 
IgG,  and  patient  Far  (Table  If),  whose  cells  displayed  no  detectable  Ig but  did 
demonstrate  Fcy receptors  and  failed  to form rosettes  with sheep erythrocytes, thus 
strongly suggesting their B cell nature.  Plasma cells were not detectable in any of the 
populations  studied,  and  the neoplastic  lymphocytes were histologically in the cate- 
gory of the well-differentiated lymphocytic group. The intensity of surface fluorescence 
among the  different  neoplasms  was  variable  with  some  tendency  for the  3`-positive 
group to show stronger reaction. 
The results obtained by analysis of culture fluids obtained  from cells are shown as 
ng of Ig product/2  ×  107 cells per h, but all cultures were monitored hourly over 5-6 
h,  and  production  was only considered  positive  where  amounts  in  the  supernatant 
increased  with  time.  The patterns  of Ig export  were variable,  but  all  the neoplastic 
populations appeared  to export light chain of either K or 3` type, which corresponded 
to the surface Ig light chain.  The light chains exported were presumably free rather 
than combined in Ig molecules, as they are in excess over the IgM and IgD, and have 
been demonstrated previously (7)  by separation of culture fluids of patients Wat and 
War (Table I). 
The  amounts  of IgM found  in  culture  fluids  were  also  variable  among different 
neoplastic  populations.  Levels  of <2  ng  IgM/2  X  107  cells  per  h  were  considered 
negative due to the limitations of the assay. Thus 8/12 of cells of the K type (Table I) 
and 8/11  of the 3` type (Table II) exported significant amounts of IgM. 
The major difference  between  the h:-positive and  the 3.-positive groups was in the 
export  of IgD. The assay for IgD is more sensitive  and  levels of <1  ng IgD/2 ×  107 
cells/h  were  considered  negative.  Thus  10/12  neoplastic  populations  of the  3` type 
showed significant levels of exported lgD (160-620 molecules of monomer/cell per h), 
whereas 0/12 of the g type exported IgD. There was no apparent  association between 
export  of IgM and  IgD, and  some populations  (Sur  and  Mai  in  Table  1)  exported 
only IgD. 
Discussion 
The  majority of normal  B  lymphocytes in  human  peripheral  blood  display  both 
IgM and IgD, and there  is predominance  of the x light  chain  type (1).  Similarly,  in STEVENSON  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
Surface Expression and Export of lg by Lymphocytes  from Patients with B cell Neoplasms of the 
Light Chain Type 
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Source of 
Patient  Disease*  lymphocytes  Surface Ig:~ isotypes 
Exported Ig~ 
IgM  IgD  x  3, 
ng/2  ×  107cetls/h 
Bee  NHL  Lymph node  IgM(D)G3, ++  7.4  1,0  0  46 
Bun  CLL  Blood  IgMDG3, ++  1.4  3.8  0  22 
Phi  CLL  Blood  IgMDG3, +  6,8  1.7  0  24 
Sto  CLL  Blood  IgMDGx3, ++  12  3.3  0  19 
Sur  NHL  Blood  Ix(M) D3` ++  0  2.3  0  55 
Mai  CLL  Blood  IgMG)k (+)  0  1.8  0  47 
Wat  CLL  Blood  IgMDG3, ++  14  3.3  0  14 
War  CLL  Blood  IgMDG~ +  9.5  1.3  0  31 
'Fay  GLL  Blood  IgM(D)3, ++  9.4  2.0  0  31 
Twe  GLL  Blood  IgMD3, (+)  20  2.8  0  62 
Wet  CLL  Blood  IgM(D)3, (+)  2.2  0.4  0  43 
Hol  GLL  Blood  [gM3, (+)  0.6  0.2  0  20 
* The NHL cases were both of the well-differentiated lymphocytic lymphoma (WDLL) group. 
IgG was detectable on the cell surface of seven patients' cells but is probably extrinsic (8). Levels of fluorescence 
are indicated by plus marks, and where an individual heavy chain class is of low fluorescence it is in parentheses. 
§ Exported Ig was measured in culture fluids by RIA, The g and 3, light chain assays are relatively insensitive to 
light chain in whole Ig molecules and are detecting mainly free light chain (7). 
TABLE  II 
Surface Expression and Export of lg by Lymphocytes  from Patients with B Cell Neoplasms of the 
x Light Chain Type 
Source of 
Patient  Disease*  lymphocytes  Surface Ig:~ isotypes 
Exported Ig~ 
IgM  lgD  ~  3, 
ng/2  ×  107 cells/h 
Far  CLL  Blood  NDI]  6.5  0  20  0 
Hal  CLL  Blood  IgMDGx (+)  12  0  48  0 
Han  CLL  Blood  IgMDGx (+)  1.3  0.4  19  1.6 
Hut  NHL  Spleen  IgMDx (+)  3.7  0.5  16  0 
Owe  CLL  Blood  IgMDi¢ ++  6.6  0.4  5.6  0 
Smi  CLL  Blood  lgM (D)Cn¢ (+)  0  0.4  12  0 
Wil  CLL  Blood  IgM(D)Gx +  2.9  0  20  0 
Win  CLL  Blood  IgMDx +  0.9  0.2  28  0.5 
Woo  CLL  Blood  lgMGK (+)  20  0.2  32  0 
Ant  CLL  Blood  IgMDC~ ++  11  C.3  16  0 
Mat  NHL  Lymph node  IgMDK (+)  4.0  0  2.5  0 
* The NHL cases were both of the WDLL group. 
IgG was detectable on the cell surface of six patients' cells but is probably extrinsic (8). Levels of fluorescence are 
indicated by plus marks, and where an individual heavy chain class is of low fluorescence it is bracketed. 
§ Exported Ig was measured in culture fluids by RIA. The x and A light chain assays are relatively insensitive to 
light chain in whole Ig and are detecting mainly free light chain (7). 
II Not detected. 
the B cell neoplasms such as CLL, where cells bear IgM and IgD of the same idiotype 
(5), the greater incidence of tumors of the K type reflects the normal pattern. However, 
90% of myelomas secreting IgD are of the ~  type  (3), and  normal serum  IgD also 
appears to be mainly of the )k type (4). These findings have led to the suggestion that 
surface  and  exported  IgD  differ in  some  fundamental  way,  such  as  belonging  to 
different subclasses (9), although this has not been demonstrated (10). 
This investigation bears on this question at the level of the B  lymphocyte. It has 
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that  display IgM and  IgD can export  small  amounts of IgM  (9/9  patients)  and  in 
some cases IgD (3/9 patients) with neither Ig arising from the cell surface (7).  In our 
experience, cell surface material is found in culture fluids only as a  large molecular 
weight, possibly vesicular form which is not detected by our techniques (11), although 
it would be included  if the commonly used procedures of immune precipitation and 
electrophoresis in  denaturant  were applied.  In two of the IgD-exporting neoplasms 
for which  anti-idiotype was available, the IgD was shown  to be of the same size as 
normal  IgD  and  of the  same  idiotype  as  the  lgM  (7).  These  three  IgD-exporting 
neoplasms were all of the )~ type and are included in Table I  (Phi, Wat, and War). 
The  association  of IgD export  with  expression  of the  X light  chain  in  the  three 
patients  studied  led  to  the  present  analysis  of a  further  20  patients,  and  such  an 
association has been confirmed. Thus, the dissociation between ability to express and 
ability to export IgD is present already at the stage of the B lymphocyte, in that those 
cells  synthesizing ~  light  chain  are  able to  and  frequently  do  export  IgD, whereas 
those synthesizing x light chains are able only to express IgD. The mechanism of such 
a  dissociation  presumably  could  involve  either  lack  of biosynthetic  machinery  or 
degradation of the IgD~ destined for export. 
The ability of human  lymphoma-derived B cell lines to both express and  secrete 
IgM has been shown to arise from two independent  mRNA molecules, presumably 
derived  from  a  primary  nuclear  transcript  by  differential  splicing  (12).  A  similar 
procedure appears to operate for synthesis of membrane and secreted IgD (13).  It is 
of interest that  investigation of a  human lymphoblastoid cell line expressing surface 
IgM and IgD of g light chain type, but secreting only IgM, revealed the presence of 
two mRNA molecules encoding 6 chains (14).  One appeared to encode surface 6, the 
other a ~ chain of lower molecular weight consistent with that of secreted IgD. If such 
mRNA  is  generally  present  in  B  cells  that  express  the  ~  light  chain  type,  lack of 
secretion of IgD~ might be due to a  block subsequent  to translation.  An alternative 
possibility  for  the  failure  of cells  expressing  IgDg  to  export  IgD  is  that  the  IgD~ 
destined for export may be degraded inside the cell. A case of CLL with intracellular 
IgDK that was not secreted has been described (15), but no intracellular IgD has been 
detected  in  normal  B  lymphocytes or other cases of CLL. Therefore, if such  degra- 
dation occurs, it must be rapid. 
Summary 
An investigation has been made into the ability of human neoplastic B lymphocytes 
expressing surface IgM and IgD to export IgD in culture. Cells that expressed surface 
Ig of the X light  chain  type frequently exported IgD (10/12  patients), whereas cells 
expressing surface Ig of the ~ light chain type exported no IgD, although most (8/11 
patients)  were able to export IgM. It appears, therefore, that in most of the 23 cases 
studied,  cells synthesizing IgD with X light chains can both express and export IgD, 
whereas those synthesizing IgDg can only insert  it  into the surface membrane. This 
finding and the known preponderance of h  in plasma IgD imply that the possession 
of a  N chain  facilitates  the  IgD secretory pathway,  a  conclusion  that  implicates  a 
control  mechanism subsequent  to the surface/secretory dichotomy arising from dif- 
ferent splicings of heavy chain messenger RNA. 
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